Tuesday, 24 December 2013

Early Microvascular Changes with Loss of the Glycocalyx in Children with Type 1 Diabetes

Our results disclose the glycocalyx as a possible monitoring measurement for earlier detection of diabetic microangiopathy and may provide a basis for new therapeutic strategies aiming at protection or restoration of the glycocalyx (The Journal of Pediatrics)

Erythropoietin, a novel repurposed drug: An innovative treatment for wound healing in patients with diabetes mellitus

In this review, the mechanism of EPO's action in skin wound healing is reviewed, and its potential for treating acute and chronic skin wounds and stimulating tissue regeneration in diabetic patients is discussed (Wound Repair and Regeneration)

No comments:

Post a Comment